Low-level laser therapy in multiple sclerosis: justification and optimization methods of application. (Literature review)

Moskvin S.V.; Kochetkov A.V.; Aleksandrova N.A.; Gameeva E.V.

doi:https://doi.org/10.17116/kurort202410105145

Close metadata

OBJECTIVE

To analyze scientific data on the effectiveness and optimization of applying low-level laser therapy methods in patients with MS.

MATERIAL AND METHODS

Databases and libraries, namely PubMed, Scopus, ResearchGate, Google Scholar, J-STAGE, eLibrary.ru, were used for search. Publications of interest towards analysis of the ways of optimization of low-level laser therapy techniques and its effectiveness improvement, prospects for the development of this treatment method were selected. The total number of publications equal 87, mostly in English and Russian, was found.

RESULTS

It was demonstrated, that low-level laser therapy can be considered a promising method of MS treatment. Mechanisms of therapeutic action of low-intensity laser radiation were shown, as well as the results of several clinical studies were presented.

CONCLUSION

It was concluded that optimal values of all technique’s indicators, namely wavelength, operation mode, power, frequency, exposure, etc., should be used. Laser blood irradiation (intravenous or external) and laser acupuncture, systemic techniques of low-level laser therapy are obligatory carried out with local irradiation of lesions.

Keywords:

autoimmune and neurodegenerative diseases

multiple sclerosis

low-level laser therapy

treatment techniques

Authors:

Moskvin S.V.

Academy of Postgraduate Education of the Federal Clinical and Scientific Center for Specialized Medical Care and Technologies of the Federal Biological Medical Agency

ORCID: 0000-0002-1503-0742

Kochetkov A.V.

Academy of Postgraduate Education of the Federal Clinical and Scientific Center for Specialized Medical Care and Technologies of the Federal Biological Medical Agency

ORCID: 0000-0002-1950-8897

Aleksandrova N.A.

Academy of Postgraduate Education of the Federal Clinical and Scientific Center for Specialized Medical Care and Technologies of the Federal Biological Medical Agency

ORCID: 0009-0003-6811-7061

Gameeva E.V.

Federal Scientific and Clinical Center of Medical Rehabilitation and Balneology of the Federal Medical-Biological Agency

SPIN RSCI: 9423-7155
ORCID: 0000-0002-8509-4338

Received:

11.04.2024

Accepted:

20.06.2024

Close metadata

References:

Bogolepova AN, Vasenina EE, Gomzyakova NA, Gusev EI, Dudchenko NG, Emelin AYu, Zalutskaya NM, Isaev RI, Kotovskaya YuV, Levin OS, Litvinenko IV, Lobzin VYu, Martynov MU, Mkhitaryan EA, Neznanov NG, Palchikova EI, Tkacheva ON, Cherdak MA, Chimagomedova ASh, Yakhno NN. Clinical Guidelines for Cognitive Disorders in Elderly and Older Patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(10-3):6-137. (In Russ.). https://doi.org/10.17116/jnevro20211211036
Rasseyannyi skleroz. Klinicheskie rekomendatsii. Moskva: MZ RF; 2022. (In Russ.).
Kil’dyushevskii AV. Ekstrakorporal’naya gemokorrektsiya pri limfoproliferativnykh i autoimmunnykh zabolevaniyakh: Avtoref. dis. … d-ra med. nauk. Moscow; 1997. (In Russ.).
Patent RUS №2005513/15.01.1994. Chentsova OB, Ol’shanskii AYa, Kil’dyushevskii AV, Grechanyi MP, Ryabtseva AA, Fialkovskii SYu. Sposob lecheniya autoimmunnykh zabolevanii. Accessed April 01, 2024. (In Russ.). https://www.fips.ru/iiss/document.xhtml?faces-redirect=true&id=9172b5db81ee6a4347a0e04158e6c82e
Chemeris AN, Dmitriev AA, Pavlova IG. Rol’ plazmafereza v kompleksnom lechenii rasseyannogo skleroza. Materialy Nauchno-prakticheskoi konferentsii TsFO RF «Aktual’nye voprosy zamestitel’noi pochechnoi terapii, gemafereza i transplantatsionnoi koordinatsii». Moscow; 2010. (In Russ.).
Moskvin SV, Khadartsev AA. Methods of effective low-level laser therapy in the treatment of patients with bronchial asthma. BioMedicine. 2020;10(1):1-20. https://doi.org/10.37796/2211-8039.1000
Moskvin SV. A brief literature review of low-level laser therapy for treating amyotrophic lateral sclerosis and confirmation of its effectiveness. BioMedicine. 2024;14(1):1-9. https://doi.org/10.37796/2211-8039.1430
Moskvin SV, Chernova NI. Laser therapy for herves virus infections (literature review). Journal of New Medical Technologies, e-edition. 2019;13(4):122-137. (In Russ.). https://doi.org/10.24411/2075-4094-2019-16467
Perlamutrov YuN, Chernova NI, Ol’khovskaia KB, Moskvin SV. Combined laser therapy of the reactivated form of cytomegalovirus infection of the urogenital tract in the women of reproductive age. Problems of Balneology, Physiotherapy and Exercise Therapy. 2013;90(3):45-51. (In Russ.).
Anju M, Chacko L, Chettupalli Y, et al. Effect of Low Level Laser Therapy on serum vitamin D and magnesium levels in patients with diabetic peripheral neuropathy ‒ A pilot study. Diabetes Metab Syndr. 2019;13(2):1087-1091. https://doi.org/10.1016/j.dsx.2019.01.022
Heiskanen V, Pfiffner M, Partonen T. Sunlight and health: shifting the focus from vitamin D3 to photobiomodulation by red and near-infrared light. Ageing Res Rev. 2020;61:101089. https://doi.org/10.1016/j.arr.2020.101089
Sosin IK, Chuev YuF. Tabachnaya zavisimost’. Kharkov; 2003. (In Russ.).
Bicknell B, Laakso EL, Liebert A, Kiat H. Modifying the microbiome as a potential mechanism of photobiomodulation: a case report. Photobiomodul Photomed Laser Surg. 2022;40(2):88-97. https://doi.org/10.1089/photob.2021.0057
Barbas IM, Skoromets AA. Rasseyannyi skleroz. Opyt lecheniya, profilaktika obostrenii. Saint Petersburg: Sotisb; 2003. (In Russ.).
Burmistrova MV, Ponomarenko GN, Odinak MM. Limfodreniruyushchie effekty infrakrasnogo lazernogo izlucheniya i geparin-elektroforeza u bol’nykh rasseyannym sklerozom. Problems of Balneology, Physiotherapy and Exercise Therapy. 2001;2:31-33. (In Russ.).
Zhadin MN, Zakharova NM, Karneev AN, Marushak II. Izmeneniya elektricheskoi aktivnosti perezhivayushchego sreza neokorteksa morskoi svinki kak prognosticheskii pokazatel’ effektivnosti lazernoi terapii u bol’nykh, stradayushchikh rasseyannym sklerozom. Biomeditsina. 2007;6:97-102. (In Russ.).
Zagumennikov SYu, Lubarskii MS, Smagin AA, Rot TA, Zemtsova NM, Zuevskii VP, Prokop’ev MN. Laser therapy in the combined treatment of disseminated sclerosis. Laser medicine. 2002;6(3):42-44. (In Russ.).
Macheret EL, Yarosh AA, Korkushko AO. Vliyanie nizkoenergeticheskogo lazernogo izlucheniya na kliniko-immunologicheskie pokazateli u bol’nykh rasseyannym sklerozom. Deistvie nizkoenergeticheskogo lazernogo izlucheniya na krov’. Kiev; 1989:130-132. (In Russ.).
Patent USSR №1364352/07.01.1988. Byul. №1. Gusev EI, Polonskii AK, Dubrovskaya MK, Lapochkin OL, Dubrovskaya NI. Sposob lecheniya narushenii mocheispuskaniya u bol’nykh rasseyannym sklerozom. Accessed April 01, 2024. (In Russ.). https://patents.su/3-1364352-sposob-lecheniya-narushenijj-mocheispuskaniya-u-bolnykh-rasseyannym-sklerozom.html
Patent RUS №2005457/15.01.1994. Chernyak LA. Sposob lecheniya rasseyannogo skleroza. Accessed April 01, 2024. (In Russ.). https://www.fips.ru/iiss/document.xhtml?faces-redirect=true&id=533507bc3f8f4d54e90fb3feb3ff0653
Patent RUS №2200041/10.03.2003. Ovsyannikov VA, Eliseeva IM, El’chaninov AP, Burmistrova MV. Sposob lecheniya bol’nykh rasseyannym sklerozom lazernym izlucheniem. Accessed April 01, 2024. (In Russ.). https://www.fips.ru/iiss/document.xhtml?faces-redirect=true&id=b4fc0e7a7cde4ac970c8d3e3256d3991
Patent BY №9098/30.06.2006. Nedz’ved’ GK, Kolenchits NI, Tishina LA. Sposob lecheniya rasseyannogo skleroza. Accessed April 01, 2024. (In Russ.). https://bypatents.com/3-9098-sposob-lecheniya-rasseyannogo-skleroza.html
Posvalyuk NE. Osobennosti rasseyannogo skleroza v Dal’nevostochnom regione: Avtoref. dis. … kand. med. nauk. Novosibirsk; 1995. (In Russ.).
Tupikin GV, Timofeev VT, Goloviznin MV, Klushin YuI, Kazantseva NV, Idrisova MI. Immunomoduliruyushchii effekt lazernogo oblucheniya krovi u bol’nykh revmatoidnym artritom i rasseyannym sklerozom. Sbornik nauchnykh trudov «Infektsiya i revmaticheskie zabolevaniya». Moscow; 1994:182-190. (In Russ.).
Eninya GI, Metra MYa, Chernyakov VA. Primenenie lazernogo izlucheniya dlya lecheniya rasseyannogo skleroza. Izvestiya Latviiskoi AN. 1991;3(524):120-124. (In Russ.).
Yausheva MV. Vozmozhnosti nizkointensivnogo lazernogo izlucheniya v lechenii bol’nykh rasseyannym sklerozom: Avtoref. dis. … kand. med. nauk. Kazan; 2005. (In Russ.).
Essa SA, Shendy WS. Photobiomodulation for relapsing–remitting multiple-sclerosis management: a nonrandomized controlled trial. Kasr Al Ainy Med J. 2021;27:62-68. https://doi.org/10.4103/kamj.kamj_21_21
Essa SA, Mostafa YM, Fathi SM, et al. Could phototherapy reverse visual deficits in patients with relapsing-remitting multiple sclerosis? J Med Sci Clin Res. 2015;3(5):5479-5494. https://doi.org/10.18535/jmscr
Essa S, Mostafa Y, Fathi S, et al. Spasticity is modifiable through phototherapy in patients with relapsing remitting multiple sclerosis: a randomized controlled study. Kasr Al Ainy Med J. 2016;22(3):81-90. https://doi.org/10.4103/2356-8097.195887.
Gonçalves MLL, Kalil Bussadori S, Dadalti Fragoso Y, et al. Effect of photodynamic therapy in the reduction of halitosis in patients with multiple sclerosis: clinical trial. J Breath Res. 2017;11(4):046006. https://doi.org/10.1088/1752-7163/aa8209
Koyama T, Ohshiro T. Low reactive-level laser therapy improved systemic sclerosis-associated Raynaud’s phenomenon. Laser Therapy. 2007;16(3):151-157. https://doi.org/10.5978/islsm.16.151
Kubsik A, Klimkiewicz P, Woldańska-Okońska M. Zastosowanie promieniowania laserowego w fizjoterapii chorych na stwardnienie rozsiane. Wiad Lek. 2012;65(1):55-61. KubsikA,KlimkiewiczP,Woldańska-OkońskaM.Applicationoflasertherapyinthephysiotherapyofpatientswithmultiplesclerosis.WiadLek.2012;65(1):55-61.(InPolish).
Kubsik A, Klimkiewicz R, Janczewska K, et al. Application of laser radiation and magnetostimulation in therapy of patients with multiple sclerosis. NeuroRehabilitation. 2016;38(2):183-190. https://doi.org/10.3233/NRE-161309.
Peszyński-Drews C, Klimek A, Sopinski M, Obrzejta D. Laser biostimulation of patients suffering from multiple sclerosis in respect to the biological influence of laser light. Proc. SPIE 5229, Laser Technology VII: Applications of Lasers. 2003;97-103. https://doi.org/10.1117/12.520611
Peszyński-Drews C, Sztamska E, Klimek A. Rehabilitacja laserowa w zaawansowanych postaciach postępującego stwardnienia rozsianego. Acta Bio-Optica et Informatica Medica. Inżynieria Biomedyczna. 2006;12(3):179-181.
Schumm N. Intravenöse Laserblutbestrahlung bei Multipler Sklerose: ein neues Therapieverfahren mit signifikanter Verbesserung der Lebensqualität. Komplementäre und Integrative Medizin. 2008;49(11-12):38-43. https://doi.org/10.1016/j.kim.2008.10.001
Seada YI, Nofel R, Sayed HM. Comparison between trans-cranial electromagnetic stimulation and low-level laser on modulation of trigeminal neuralgia. J Phys Ther Sci. 2013;25(8):911-914. https://doi.org/10.1589/jpts.25.911
Silva T, Fragoso YD, Destro Rodrigues MFS, et al. Effects of photobiomodulation on interleukin-10 and nitrites in individuals with relapsing-remitting multiple sclerosis ‒ Randomized clinical trial. PLoS One. 2020;15(4):e0230551. https://doi.org/10.1371/journal.pone.0230551
Tolentino M. Characterization of the effect of photobiomodulation on peripheral blood mononuclear cells and Cd4+ T cells from healthy donors and multiple sclerosis subjects [dissertation]. University of Wisconsin-Milwaukee; 2020.
Tolentino M, Cho CC, Lyons JA. Photobiomodulation at 830 nm Reduced Nitrite Production by Peripheral Blood Mononuclear Cells Isolated from Multiple Sclerosis Subjects. Photobiomodul Photomed Laser Surg. 2022;40(7):480-487. https://doi.org/10.1089/photob.2021.0170
Tolentino M, Cho CC, Lyons JA. Photobiomodulation Modulates Interleukin-10 and Interferon Gamma Production by Mononuclear Cells from Healthy Donors and Persons with Multiple Sclerosis. Photobiomodul Photomed Laser Surg. 2022;40(4):234-244. https://doi.org/10.1089/photob.2021.0169
Maksimchuk LV, Makhovskaya TG, Khandurina GN, Shcherbonosova TA, Germanovich VV, Lolstonogova VI, Rafikov NM, Posvalyuk NE, Avramenko SP, Matvienko EV, Khelimskaya EA, Petrichko GI, Kaufman SS. Lazeroterapiya v nevrologicheskoi i neirokhirurgicheskoi praktike. Lazernaya terapiya v praktike vracha. Vladivostok; 1994:204-218. (In Russ.).
Skupchenko VV, Makhovskaya TG, Serdyuk NB, Mironova LP. Endovaskulyarnaya lazeroterapiya v nevrologicheskoi praktike. Deistvie elektromagnitnogo izlucheniya na biologicheskie ob”ekty i lazernaya meditsina. Vladivostok: DVO AN SSSR; 1989:197-212. (In Russ.).
Skupchenko VV, Makhovskaya TG. Lazernaya terapiya v nevrologii. — Samara-Khabarovsk; 1993. (In Russ.).
Matveeva TV. O roli timusa v patogeneze rasseyannogo skleroza: Avtoref. dis.... kand. med. nauk. Minsk; 1975. (In Russ.).
Mel’nik NA. Struktura nekotorykh organov nervnoi i immunnoi sistem v usloviyakh demielinizatsii i remilinizatsii: Avtoref. dis. … d-ra med. nauk. Kiev; 2005. (In Russ.).
Gonçalves ED, Souza PS, Lieberknecht V, et al. Low-level laser therapy ameliorates disease progression in a mouse model of multiple sclerosis. Autoimmunity. 2016;49(2):132-142. https://doi.org/10.3109/08916934.2015.1124425
Muili KA, Gopalakrishnan S, Meyer SL, et al. Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by photobiomodulation induced by 670 nm light. PLoS One. 2012;7(1):e30655. https://doi.org/10.1371/journal.pone.0030655
Muili KA, Gopalakrishnan S, Eells JT, Lyons JA. Photobiomodulation induced by 670 nm light ameliorates MOG35-55 induced EAE in female C57BL/6 mice: a role for remediation of nitrosative stress. PLoS One. 2013;8(6):e67358. https://doi.org/10.1371/journal.pone.0067358
Nwosu U. Analysis of how B cells contribute to the photobiomodulation technique in regards to multiple sclerosis. Proceedings of the National Conference on Undergraduate Research (NCUR); 2018:420-427.
Duarte KCN, Soares TT, Magri AMP, et al. Low-level laser therapy modulates demyelination in mice. J Photochem Photobiol B. 2018;189:55-65. https://doi.org/10.1016/j.jphotobiol.2018.09.024
Farid MF, Abouelela YS, Yasin NAE, et al. Laser-activated autologous adipose tissue-derived stromal vascular fraction restores spinal cord architecture and function in multiple sclerosis cat model. Stem Cell Res Ther. 2023;14(1):6. https://doi.org/10.1186/s13287-022-03222-2
Abdallah AN, Shamaa AA, El-Tookhy OS. Evaluation of treatment of experimentally induced canine model of multiple sclerosis using laser activated non-expanded adipose derived stem cells. Res Vet Sci. 2019;125:71-81. https://doi.org/10.1016/j.rvsc.2019.05.016
Moskvin SV, Klyuchnikov DYu, Volchkov SE, Antipov EV, Supilnikov AA, Kiselyova ON. Influence of the pulse low-intensive laser radiation on culture of mesenchymal stem cells of the person of in vitro. Morphological Newsletter. 2014;3:59-65. (In Russ.).
Hossein-Khannazer N, Kazem Arki M, Keramatinia A, Rezaei-Tavirani M. The Role of Low-Level Laser Therapy in the Treatment of Multiple Sclerosis: A Review Study. J Lasers Med Sci. 2021;12:e88. https://doi.org/10.34172/jlms.2021.88
Tolentino MA, Lyons JA. Photobiomodulation for multiple sclerosis in animal models. In: Hamblin MR, Huang YY, eds. Photobiomodulation in the Brain. Low-Level Laser (Light) Therapy in Neurology and Neuroscience. London: Academic Press, an imprint of Elsevier; 2019:241-251. https://doi.org/10.1016/B978-0-12-815305-5.00019-1
Moskvin SV, Ryzhova TV. Lazernaya terapiya v endokrinologii. Seriya «Effektivnaya lazernaya terapiya». Vol. 5. Moscow: IP Moskvin S.V.; Tver: OOO «Izdatel’stvo «Triada», 2020. (In Russ.).
Mikusev YuE, Yausheva MV, Matveeva TV. Effects of low-intensity laser radiation on immune reactivity. Russian journal of physiotherapy, balneology and rehabilitation. 2003;3:39-43. (In Russ.).
Alshial EE, Abdulghaney MI, Wadan AS, et al. Mitochondrial dysfunction and neurological disorders: A narrative review and treatment overview. Life Sci. 2023;334:122257. https://doi.org/10.1016/j.lfs.2023.122257
Johnson J, Mercado-Ayon E, Mercado-Ayon Y, et al. Mitochondrial dysfunction in the development and progression of neurodegenerative diseases. Arch Biochem Biophys. 2021;702:108698. https://doi.org/10.1016/j.abb.2020.108698
Vafaei-Nezhad S, Niknazar S, Payvandi AA, et al. Therapeutic Effects of Photobiomodulation Therapy on Multiple Sclerosis by Regulating the Inflammatory Process and Controlling Immune Cell Activity: A Novel Promising Treatment Target. J Lasers Med Sci. 2022;13:e32. https://doi.org/10.34172/jlms.2022.32
George Z, Tolentino MA, Lyons JA. Low-level laser therapy: a treatment modality for multiple sclerosis targeting autoimmunity and oxidative stress. In: Hamblin MR, de Sousa MVP, Agrawal T, eds. Handbook of Low-Level Laser Therapy. Pan Stanford Publishing Pte. Ltd.; 2017:491-501.
Liang J, Liu L, Xing D. Photobiomodulation by low-power laser irradiation attenuates Aβ-induced cell apoptosis through the Akt/GSK3β/β-catenin pathway. Free Radic Biol Med. 2012;53(7):1459-1467. https://doi.org/10.1016/j.freeradbiomed.2012.08.003
da Silva T, da Silva FC, Gomes AO, et al. Effect of photobiomodulation treatment in the sublingual, radial artery region, and along the spinal column in individuals with multiple sclerosis: Protocol for a randomized, controlled, double-blind, clinical trial. Medicine (Baltimore). 2018;97(19):e0627. https://doi.org/10.1097/MD.0000000000010627
Silva T, Fragoso YD, Destro Rodrigues MFS, et al. Effects of photobiomodulation on interleukin-10 and nitrites in individuals with relapsing-remitting multiple sclerosis ‒ Randomized clinical trial. PLoS One. 2020;15(4):e0230551. https://doi.org/10.1371/journal.pone.0230551
Alvarenga-Filho H, Sacramento PM, Ferreira TB, et al. Combined exercise training reduces fatigue and modulates the cytokine profile of T-cells from multiple sclerosis patients in response to neuromediators. J Neuroimmunol. 2016;293:91-99. https://doi.org/10.1016/j.jneuroim.2016.02.014
Wong VL, Holahan MR. A systematic review of aerobic and resistance exercise and inflammatory markers in people with multiple sclerosis. Behav Pharmacol. 2019;30(8):653-660. https://doi.org/10.1097/FBP.0000000000000514
De Marchi T, Leal Junior EC, Bortoli C, et al. Low-level laser therapy (LLLT) in human progressive-intensity running: effects on exercise performance, skeletal muscle status, and oxidative stress. Lasers Med Sci. 2012;27(1):231-236. https://doi.org/10.1007/s10103-011-0955-5
Leal Junior EC, Lopes-Martins RA, Baroni BM, et al. Comparison between single-diode low-level laser therapy (LLLT) and LED multi-diode (cluster) therapy (LEDT) applications before high-intensity exercise. Photomed Laser Surg. 2009;27(4):617-623. https://doi.org/10.1089/pho.2008.2350
Leal Junior EC, Lopes-Martins RA, Rossi RP, et al. Effect of cluster multi-diode light emitting diode therapy (LEDT) on exercise-induced skeletal muscle fatigue and skeletal muscle recovery in humans. Lasers Surg Med. 2009;41(8):572-577. https://doi.org/10.1002/lsm.20810
Leal-Junior ECP, de Oliveira MFD, Joensen J, et al. What is the optimal time-response window for the use of photobiomodulation therapy combined with static magnetic field (PBMT-sMF) for the improvement of exercise performance and recovery, and for how long the effects last? A randomized, triple-blinded, placebo-controlled trial. BMC Sports Sci Med Rehabil. 2020;12:64. https://doi.org/10.1186/s13102-020-00214-8
Tolentino MA, Cho C, Rouhani M, et al. Photobiomodulation therapy for the treatment of multiple sclerosis: the effect of PBMT on the immune response and muscle function. Book of Abstracts virtual summit «PBM2021»; 2021:70.
Pinto AP, Guimarães CL, Souza GADS, et al. Sensory-motor and cardiorespiratory sensory rehabilitation associated with transcranial photobiomodulation in patients with central nervous system injury: Trial protocol for a single-center, randomized, double-blind, and controlled clinical trial. Medicine (Baltimore). 2019;98(25):e15851. https://doi.org/10.1097/MD.0000000000015851
David AC, Zamuner SR. Efeito da fotobiomodulação na modulação da interleucina-10: revisão narrativa de estudos clínicos. Semina: Ciências Biológicas e da Saúde. 2021;42(2):235-242. https://doi.org/10.5433/1679-0367.2021v42n2p235
Martusevich AK. Oksid azota kak universal’nyi bioregulyator. Bioradikaly i Antioksidanty. 2019;6(1):5-19. (In Russ.).
Evtushenko SK, Grishchenko AB, Derevyanko IN, Simonyan VA, Vinokurov DL, Lisovsky EV, Savchenko EA Role of a pathological tortuosity, hypo- and aplasias of precerebral vessels at progreduatedly current forms of multiple sclerosis. International neurological journal. 2007;4(14):39-44. (In Russ.).
Moskvin SV. Osnovy lazernoi terapii. Seriya «Effektivnaya lazernaya terapiya». Vol. 1. Moscow-Tver: Izdatel’stvo «Triada»; 2016 (In Russ.).
Moskvin SV, Kochetkov AV. Russian low level laser therapy techniques for brain disorders. In: Hamblin MR, Huang YY, eds. Photobiomodulation in the Brain. Low-Level Laser (Light) Therapy in Neurology and Neuroscience. London: Academic Press, an imprint of Elsevier, 2019:545-572. https://doi.org/10.1016/B978-0-12-815305-5.00040-3
Zhai D, Yan S, Samsom J, et al. Small-molecule targeting AMPA-mediated excitotoxicity has therapeutic effects in mouse models for multiple sclerosis. Sci Adv. 2023;9(49):eadj6187. https://doi.org/10.1126/sciadv.adj6187
Huang YY, Nagata K, Tedford CE, Hamblin MR. Low-level laser therapy (810 nm) protects primary cortical neurons against excitotoxicity in vitro. J Biophotonics. 2014;7(8):656-664. https://doi.org/10.1002/jbio.201300125
Shen Q, Liu L, Gu X, Xing D. Photobiomodulation suppresses JNK3 by activation of ERK/MKP7 to attenuate AMPA receptor endocytosis in Alzheimer’s disease. Aging Cell. 2021;20(1):e13289. https://doi.org/10.1111/acel.13289
Thompson AJ, Baneke P. Multiple Sclerosis International Federation (MSIF) Design and Editorial Support by Summers Editorial & Design Graphics by Nutmeg Productions Printed by Modern Colour Solutions; 2013 [cited 2020 Apr 13]. Available from: www.msif.org.
Moskvin SV. Only lasers can be used for low level laser therapy. BioMedicine. 2017;7(4):4-11. https://doi.org/10.1051/bmdcn/2017070422
Moskvin SV. Low-Level Laser Therapy and Light Energy. Photobiomodul Photomed Laser Surg. 2019;37(5):267-268. https://doi.org/10.1089/photob.2019.4622
Samways AP, Menegusso D, Guimaraes AFS, Bunemer L. Effects of PBM in multiple sclerosis — case report. Book of Abstracts virtual summit «PBM2021»; 2021:91.